81_FR_12561 81 FR 12515 - Notice of Diabetes Mellitus Interagency Coordinating Committee Meeting

81 FR 12515 - Notice of Diabetes Mellitus Interagency Coordinating Committee Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 81, Issue 46 (March 9, 2016)

Page Range12515-12516
FR Document2016-05209

The Diabetes Mellitus Interagency Coordinating Committee (DMICC) will hold a meeting on March 29, 2016. The subject of the meeting will be initiatives in natural experiments for diabetes prevention and control being sponsored by the Centers for Disease Control and Prevention, the National Institute of Diabetes and Digestive and Kidney Diseases, and the Patient-Centered Outcomes Research Institute. The meeting is open to the public.

Federal Register, Volume 81 Issue 46 (Wednesday, March 9, 2016) 
[Federal Register Volume 81, Number 46 (Wednesday, March 9, 2016)]
[Notices]
[Pages 12515-12516]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2016-05209]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Notice of Diabetes Mellitus Interagency Coordinating Committee 
Meeting

SUMMARY: The Diabetes Mellitus Interagency Coordinating Committee 
(DMICC) will hold a meeting on March

[[Page 12516]]

29, 2016. The subject of the meeting will be initiatives in natural 
experiments for diabetes prevention and control being sponsored by the 
Centers for Disease Control and Prevention, the National Institute of 
Diabetes and Digestive and Kidney Diseases, and the Patient-Centered 
Outcomes Research Institute. The meeting is open to the public.

DATES: The meeting will be held on March 29, 2016 from 1:00 p.m. to 
4:30 p.m. Individuals wanting to present oral comments must notify the 
contact person at least 10 days before the meeting date.

ADDRESSES: The meeting will be held in the NIH campus, 9000 Rockville 
Pike, Bethesda, MD 20892-2560, Building 31, Conference Room 6C6.

FOR FURTHER INFORMATION CONTACT: For further information concerning 
this meeting, see the DMICC Web site, www.diabetescommittee.gov, or 
contact Dr. B. Tibor Roberts, Executive Secretary of the Diabetes 
Mellitus Interagency Coordinating Committee, National Institute of 
Diabetes and Digestive and Kidney Diseases, 31 Center Drive, Building 
31A, Room 9A19, MSC 2560, Bethesda, MD 20892-2560, telephone: 301-496-
6623; FAX: 301-480-6741; email: [email protected].

SUPPLEMENTARY INFORMATION: The DMICC, chaired by the National Institute 
of Diabetes and Digestive and Kidney Diseases (NIDDK) comprising 
members of the Department of Health and Human Services and other 
federal agencies that support diabetes-related activities, facilitates 
cooperation, communication, and collaboration on diabetes among 
government entities. DMICC meetings, held several times a year, provide 
an opportunity for Committee members to learn about and discuss current 
and future diabetes programs in DMICC member organizations and to 
identify opportunities for collaboration. The March 29, 2016 DMICC 
meeting will focus on initiatives in natural experiments for diabetes 
prevention and control.
    Any member of the public interested in presenting oral comments to 
the Committee should notify the contact person listed on this notice at 
least 10 days in advance of the meeting. Interested individuals and 
representatives or organizations should submit a letter of intent, a 
brief description of the organization represented, and a written copy 
of their oral presentation in advance of the meeting. Only one 
representative of an organization will be allowed to present; oral 
comments and presentations will be limited to a maximum of 5 minutes. 
Printed and electronic copies are requested for the record. In 
addition, any interested person may file written comments with the 
Committee by forwarding their statement to the contact person listed on 
this notice. The statement should include the name, address, telephone 
number and when applicable, the business or professional affiliation of 
the interested person. Because of time constraints for the meeting, 
oral comments will be allowed on a first-come, first-serve basis.
    Members of the public who would like to receive email notification 
about future DMICC meetings should register for the listserv available 
on the DMICC Web site, www.diabetescommittee.gov.

    Dated: March 3, 2016.
B. Tibor Roberts,
Executive Secretary, DMICC, Office of Scientific Program and Policy 
Analysis, National Institute of Diabetes and Digestive and Kidney 
Diseases, National Institutes of Health.
[FR Doc. 2016-05209 Filed 3-8-16; 8:45 am]
 BILLING CODE 4140-01-P

Federal Register / Vol. 81, No. 46 / Wednesday, March 9, 2016 / Notices 12515 357: Understanding Alzheimer’s Disease in Date: March 29, 2016. DEPARTMENT OF HEALTH AND the Context of the Aging Brain. Time: 8:00 a.m. to 6:00 p.m. HUMAN SERVICES Date: March 16–17, 2016. Agenda: To review and evaluate grant Time: 11:00 a.m. to 5:30 p.m. applications. National Institutes of Health Agenda: To review and evaluate grant Place: National Institutes of Health, 6701 applications. Rockledge Drive, Bethesda, MD 20892 National Institute of Diabetes and Place: National Institutes of Health, 6701 (Virtual Meeting). Contact Person: Atul Sahai, Ph.D., Digestive and Kidney Diseases; Notice Rockledge Drive, Bethesda, MD 20892, (Virtual Meeting). Scientific Review Officer, Center for of Closed Meeting Contact Person: Boris P. Sokolov, Ph.D., Scientific Review, National Institutes of Pursuant to section 10(d) of the Scientific Review Officer, Center for Health, 6701 Rockledge Drive, Room 2188, Federal Advisory Committee Act, as Scientific Review, National Institutes of MSC 7818, Bethesda, MD 20892, 301–435– Health, 6701 Rockledge Drive, Room 5217A, 1198, sahaia@csr.nih.gov. amended (5 U.S.C. App.), notice is MSC 7846, Bethesda, MD 20892, 301–408– hereby given of the following meeting. Name of Committee: Center for Scientific 9115, bsokolov@csr.nih.gov. Review Special Emphasis Panel; The meeting will be closed to the This notice is being published less than 15 Fellowships: Risk, Prevention and Health public in accordance with the days prior to the meeting due to the timing Behavior. provisions set forth in sections limitations imposed by the review and Date: March 29, 2016. 552b(c)(4) and 552b(c)(6), title 5 U.S.C., funding cycle. Time: 8:00 a.m. to 5:00 p.m. as amended. The grant applications and Name of Committee: Center for Scientific Agenda: To review and evaluate grant the discussions could disclose Review Special Emphasis Panel; PAR Panel; applications. confidential trade secrets or commercial Ethical, Legal and Policy Issues in Research Place: Embassy Suites at the Chevy Chase property such as patentable material, on HIV/AIDS and its Co-Morbidities. Pavilion, 4300 Military Road NW., Washington, DC 20015. and personal information concerning Date: March 18, 2016. individuals associated with the grant Time: 10:00 a.m. to 6:00 p.m. Contact Person: Lee S. Mann, Ph.D., Agenda: To review and evaluate grant Scientific Review Officer, Center for applications, the disclosure of which applications. Scientific Review, National Institutes of would constitute a clearly unwarranted Place: National Institutes of Health, 6701 Health, 6701 Rockledge Drive, Room 3224, invasion of personal privacy. Rockledge Drive, Bethesda, MD 20892 MSC 7808, Bethesda, MD 20892, 301–435– Name of Committee: National Institute of (Virtual Meeting). 0677, mannl@csr.nih.gov. Diabetes and Digestive and Kidney Diseases Contact Person: Shalanda A. Bynum, MPH, Name of Committee: Center for Scientific Special Emphasis Panel; K12 Pediatric Ph.D., Scientific Review Officer, Center for Review Special Emphasis Panel; Member Endocrinologist Career Development Program Scientific Review, National Institutes of Conflict: Pathogenic Eukaryotes and Vectors. Grant Review. Health, 6701 Rockledge Drive Room 3206, Date: March 29, 2016. Date: April 8, 2016. Bethesda, MD 20892, 301–755–4355, Time: 10:00 a.m. to 6:00 p.m. Time: 2:00 p.m. to 4:00 p.m. bynumsa@csr.nih.gov. Agenda: To review and evaluate grant Agenda: To review and evaluate grant This notice is being published less than 15 applications. applications. days prior to the meeting due to the timing Place: National Institutes of Health, 6701 Place: National Institutes of Health, Two limitations imposed by the review and Rockledge Drive, Bethesda, MD 20892 Democracy Plaza, 6707 Democracy funding cycle. (Virtual Meeting). Boulevard, Bethesda, MD 20892, (Telephone Contact Person: John C. Pugh, Ph.D., Conference Call). Name of Committee: Center for Scientific Scientific Review Officer, Center for Contact Person: Carol J. Goter-Robinson, Review Special Emphasis Panel; HIV/AIDS Innovative Research Applications. Scientific Review, National Institutes of Ph.D., Scientific Review Officer, Review Date: March 24–25, 2016. Health, 6701 Rockledge Drive, Room 3114, Branch, DEA, NIDDK, National Institutes of Time: 10:00 a.m. to 6:00 p.m. MSC 7808, Bethesda, MD 20892, (301) 435– Health, Room 7347, 6707 Democracy Agenda: To review and evaluate grant 2398, pughjohn@csr.nih.gov. Boulevard, Bethesda, MD 20892–5452, (301) applications. Name of Committee: Center for Scientific 594–7791, goterrobinsonc@ Place: National Institutes of Health, 6701 Review Special Emphasis Panel; Vascular extra.niddk.nih.gov. Rockledge Drive, Bethesda, MD 20892 Biology and Hematology AREA. (Catalogue of Federal Domestic Assistance (Virtual Meeting). Date: March 29, 2016. Program Nos. 93.847, Diabetes, Contact Person: Jingsheng Tuo, Ph.D., Time: 2:00 p.m. to 4:30 p.m. Endocrinology and Metabolic Research; Scientific Review Officer, Center for Agenda: To review and evaluate grant 93.848, Digestive Diseases and Nutrition Scientific Review, National Institutes of applications. Research; 93.849, Kidney Diseases, Urology Health, 6701 Rockledge Drive, Room 5207, Place: National Institutes of Health, 6701 and Hematology Research, National Institutes Bethesda, MD 20892, 301–451–8754, tuoj@ Rockledge Drive, Bethesda, MD 20892 of Health, HHS) nei.nih.gov. (Virtual Meeting). Dated: March 3, 2016. Name of Committee: Center for Scientific Contact Person: Larry Pinkus, Ph.D., Scientific Review Officer, Center for David Clary, Review Special Emphasis Panel, Member Scientific Review, National Institutes of Program Analyst, Office of Federal Advisory Conflict: Bioengineering Sciences. Health, 6701 Rockledge Drive, Room 4132, Committee Policy. Date: March 24, 2016. Time: 2:30 p.m. to 5:00 p.m. MSC 7802, Bethesda, MD 20892, (301) 435– [FR Doc. 2016–05201 Filed 3–8–16; 8:45 am] Agenda: To review and evaluate grant 1214, pinkusl@csr.nih.gov. BILLING CODE 4140–01–P applications. (Catalogue of Federal Domestic Assistance Place: National Institutes of Health, 6701 Program Nos. 93.306, Comparative Medicine; Rockledge Drive, Bethesda, MD 20892 93.333, Clinical Research, 93.306, 93.333, DEPARTMENT OF HEALTH AND (Telephone Conference Call). 93.337, 93.393–93.396, 93.837–93.844, HUMAN SERVICES Contact Person: Craig Giroux, Ph.D., 93.846–93.878, 93.892, 93.893, National Scientific Review Officer, BST IRG, Center Institutes of Health, HHS) National Institutes of Health Lhorne on DSK5TPTVN1PROD with NOTICES for Scientific Review, National Institutes of Dated: March 2, 2016. Health, 6701 Rockledge Drive, Room 5150, Notice of Diabetes Mellitus Interagency Anna Snouffer, Bethesda, MD 20892, 301–435–2204, Coordinating Committee Meeting girouxcn@csr.nih.gov. Deputy Director, Office of Federal Advisory Committee Policy. SUMMARY: The Diabetes Mellitus Name of Committee: Center for Scientific Review Special Emphasis Panel; Small [FR Doc. 2016–05195 Filed 3–8–16; 8:45 am] Interagency Coordinating Committee Business: Nephrology. BILLING CODE 4140–01–P (DMICC) will hold a meeting on March VerDate Sep<11>2014 15:08 Mar 08, 2016 Jkt 238001 PO 00000 Frm 00070 Fmt 4703 Sfmt 4703 E:\FR\FM\09MRN1.SGM 09MRN1

12516 Federal Register / Vol. 81, No. 46 / Wednesday, March 9, 2016 / Notices 29, 2016. The subject of the meeting will limited to a maximum of 5 minutes. 7200, Bethesda, MD 20892, 301–496–9659, be initiatives in natural experiments for Printed and electronic copies are reillymp@nhlbi.nih.gov. diabetes prevention and control being requested for the record. In addition, (Catalogue of Federal Domestic Assistance sponsored by the Centers for Disease any interested person may file written Program Nos. 93.233, National Center for Control and Prevention, the National comments with the Committee by Sleep Disorders Research; 93.837, Heart and Vascular Diseases Research; 93.838, Lung Institute of Diabetes and Digestive and forwarding their statement to the Diseases Research; 93.839, Blood Diseases Kidney Diseases, and the Patient- contact person listed on this notice. The and Resources Research, National Institutes Centered Outcomes Research Institute. statement should include the name, of Health, HHS) The meeting is open to the public. address, telephone number and when Dated: March 3, 2016. DATES: The meeting will be held on applicable, the business or professional Michelle Trout, March 29, 2016 from 1:00 p.m. to 4:30 affiliation of the interested person. p.m. Individuals wanting to present oral Because of time constraints for the Program Analyst, Office of Federal Advisory Committee Policy. comments must notify the contact meeting, oral comments will be allowed person at least 10 days before the on a first-come, first-serve basis. [FR Doc. 2016–05199 Filed 3–8–16; 8:45 am] meeting date. Members of the public who would BILLING CODE 4140–01–P ADDRESSES: The meeting will be held in like to receive email notification about the NIH campus, 9000 Rockville Pike, future DMICC meetings should register for the listserv available on the DMICC DEPARTMENT OF HEALTH AND Bethesda, MD 20892–2560, Building 31, Web site, www.diabetescommittee.gov. HUMAN SERVICES Conference Room 6C6. FOR FURTHER INFORMATION CONTACT: For Dated: March 3, 2016. National Institutes of Health further information concerning this B. Tibor Roberts, meeting, see the DMICC Web site, Executive Secretary, DMICC, Office of Center for Scientific Review; Notice of www.diabetescommittee.gov, or contact Scientific Program and Policy Analysis, Closed Meetings Dr. B. Tibor Roberts, Executive National Institute of Diabetes and Digestive Secretary of the Diabetes Mellitus Pursuant to section 10(d) of the and Kidney Diseases, National Institutes of Interagency Coordinating Committee, Health. Federal Advisory Committee Act, as National Institute of Diabetes and amended (5 U.S.C. App.), notice is [FR Doc. 2016–05209 Filed 3–8–16; 8:45 am] Digestive and Kidney Diseases, 31 hereby given of the following meetings. BILLING CODE 4140–01–P The meetings will be closed to the Center Drive, Building 31A, Room public in accordance with the 9A19, MSC 2560, Bethesda, MD 20892– provisions set forth in sections 2560, telephone: 301–496–6623; FAX: DEPARTMENT OF HEALTH AND 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 301–480–6741; email: dmicc@ HUMAN SERVICES as amended. The grant applications and mail.nih.gov. National Institutes of Health the discussions could disclose SUPPLEMENTARY INFORMATION: The confidential trade secrets or commercial DMICC, chaired by the National National Heart, Lung, and Blood property such as patentable material, Institute of Diabetes and Digestive and Institute; Notice of Closed Meeting and personal information concerning Kidney Diseases (NIDDK) comprising individuals associated with the grant members of the Department of Health Pursuant to section 10(d) of the applications, the disclosure of which and Human Services and other federal Federal Advisory Committee Act, as would constitute a clearly unwarranted agencies that support diabetes-related amended (5 U.S.C. App.), notice is invasion of personal privacy. activities, facilitates cooperation, hereby given of the following meeting. The meeting will be closed to the Name of Committee: Center for Scientific communication, and collaboration on Review Special Emphasis Panel; Par Panel: diabetes among government entities. public in accordance with the Microbiome in HIV vaccine. DMICC meetings, held several times a provisions set forth in sections Date: March 31, 2016. year, provide an opportunity for 552b(c)(4) and 552b(c)(6), title 5 U.S.C., Time: 11:00 a.m. to 3:00 p.m. Committee members to learn about and as amended. The grant applications and Agenda: To review and evaluate grant discuss current and future diabetes the discussions could disclose applications. programs in DMICC member confidential trade secrets or commercial Place: National Institutes of Health, 6701 organizations and to identify property such as patentable material, Rockledge Drive, Bethesda, MD 20892, opportunities for collaboration. The and personal information concerning (Virtual Meeting). March 29, 2016 DMICC meeting will individuals associated with the grant Contact Person: Barna Dey, Ph.D., Scientific Review Officer, Center for focus on initiatives in natural applications, the disclosure of which Scientific Review, National Institutes of experiments for diabetes prevention and would constitute a clearly unwarranted Health, 6701 Rockledge Drive, Room 3184, control. invasion of personal privacy. Bethesda, MD 20892, 301–451–2796, bdey@ Any member of the public interested Name of Committee: National Heart, Lung, mail.nih.gov. in presenting oral comments to the and Blood Institute Special Emphasis Panel; Name of Committee: Center for Scientific Committee should notify the contact Optimizing Care for Patients with Sickle Cell Review Special Emphasis Panel; Member person listed on this notice at least 10 Disease—Data Coordinating Center. Conflict: Vascular and Hematology. days in advance of the meeting. Date: April 1, 2016. Date: April 5, 2016. Interested individuals and Time: 10:00 a.m. to 3:00 p.m. Time: 8:00 a.m. to 5:00 p.m. representatives or organizations should Agenda: To review and evaluate grant Agenda: To review and evaluate grant Lhorne on DSK5TPTVN1PROD with NOTICES submit a letter of intent, a brief applications. applications. description of the organization Place: National Institutes of Health, 6701 Place: National Institutes of Health, 6701 Rockledge Drive, Room 7200, Bethesda, MD Rockledge Drive, Bethesda, MD 20892, represented, and a written copy of their 20892 (Telephone Conference Call). (Virtual Meeting). oral presentation in advance of the Contact Person: Michael P. Reilly, Ph.D., Contact Person: Natalia Komissarova, meeting. Only one representative of an Scientific Review Officer, Office of Scientific Ph.D., Scientific Review Officer, Center for organization will be allowed to present; Review/DERA National Heart, Lung, and Scientific Review, National Institutes of oral comments and presentations will be Blood Institute 6701 Rockledge Drive, Room Health, 6701 Rockledge Drive, Room 5207, VerDate Sep<11>2014 15:08 Mar 08, 2016 Jkt 238001 PO 00000 Frm 00071 Fmt 4703 Sfmt 4703 E:\FR\FM\09MRN1.SGM 09MRN1


Document Created: 2016-03-09 00:13:57
Document Modified: 2016-03-09 00:13:57
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
DatesThe meeting will be held on March 29, 2016 from 1:00 p.m. to 4:30 p.m. Individuals wanting to present oral comments must notify the contact person at least 10 days before the meeting date.
ContactFor further information concerning this meeting, see the DMICC Web site, www.diabetescommittee.gov, or contact Dr. B. Tibor Roberts, Executive Secretary of the Diabetes Mellitus Interagency Coordinating Committee, National Institute of Diabetes and Digestive and Kidney Diseases, 31 Center Drive, Building 31A, Room 9A19, MSC 2560, Bethesda, MD 20892-2560, telephone: 301-496- 6623; FAX: 301-480-6741; email: [email protected]
FR Citation81 FR 12515 
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR